# Effect of the Protein Kinase B (PKB) Gene on the Carcinogenesis of Oral Squamous Cell Carcinoma in the South Indian Population

**Authors:** Devika Nair, Mahathi Neralla, Sushmaa Chandralekha Selvakumar, Auxzilia Preethi

PMC · DOI: 10.7759/cureus.60099 · Cureus · 2024-05-11

## TL;DR

This study found that the AKT gene is overactive in oral cancer tissues in South India, suggesting it could be a target for new treatments.

## Contribution

The study demonstrates AKT gene upregulation in oral squamous cell carcinoma tissues from South Indian patients.

## Key findings

- AKT gene expression was significantly higher in OSCC tissues compared to normal tissues (p<0.05).
- Upregulated AKT is linked to increased cell proliferation and reduced apoptosis in OSCC.

## Abstract

Introduction: The most common head and neck cancer is oral squamous cell carcinoma (OSCC). It is also one of the most prevalent forms of cancer globally. The current pharmacological treatment strategy for oral cancer lacks specificity and is capable of causing various side effects. This fact highlights the increasing need for targeted therapy. Interestingly, protein kinase B (PKB), commonly referred to as the AKT serine/threonine kinase, is an oncogenic protein that controls cell development, proliferation, apoptosis, and glycogen metabolism. Thus, the present study analyzed the AKT gene expression in OSCC patient samples.

Materials and methods: A total of 25 OSCC tissue samples and normal tissue samples were collected from the patients who reported to the Department of Oral and Maxillofacial Surgery, Saveetha Dental College and Hospitals in Chennai, India. The tissues were processed for H&E staining for histopathological confirmation, and expression studies of the AKT gene were done on both healthy and proven OSCC tissue samples. The data were shown as mean ± standard deviation, and p<0.05* was considered to be statistically significant.

Results: The quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis revealed that the AKT gene had been significantly upregulated in the OSCC tissue samples when compared to normal tissues (p<0.05). Moreover, upregulated AKT is postulated to be involved in increased cell proliferation and reduced apoptosis in OSCC.

Conclusion: The gene expression analysis was done in the samples of histologically confirmed OSCC, and it revealed that the AKT gene was significantly upregulated in OSCC tissues. Thus, AKT could be postulated as a potential therapeutic target for OSCC.

## Linked entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207]
- **Diseases:** oral squamous cell carcinoma (MONDO:0004958), head and neck cancer (MONDO:0005627)

## Full-text entities

- **Genes:** PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}
- **Diseases:** cancer (MESH:D009369), oral cancer (MESH:D009062), OSCC (MESH:D000077195), head and neck cancer (MESH:D006258)
- **Chemicals:** H&amp;E (MESH:D006371), glycogen (MESH:D006003)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11164297/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11164297/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC11164297/full.md

---
Source: https://tomesphere.com/paper/PMC11164297